Log In
Sign Up
Melphalan
Indications
Multiple myeloma; carcinoma of the ovary
Dose/Application
Multiple Myeloma: Orally, initially 6 mg OD. Following dosage should be adjusted as required wkly. The drug should be discontinued after 2-3 wks for up to 4 wks until the leukocyte and platelet counts increase. Maintenance dose: 2 mg OD. IV dosage: 16 mg/m2 once at 2-wk intervals for 4 doses. The same dose should be repeated at 4-wk intervals after acceptable recovery from toxicity. Ovarian carcinoma: 0.2 mg/kg/day x 5/7 administered at intervals of 4-5 wks.Consult specialist literature for further information.
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Alkeran Tabs 2mg 25 KES5,806.35
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us